Loading...

This cutting-edge digital pharmacy occupies a strategically located Midtown Manhattan space with a highly favorable long-term lease – secured for seven years with an additional five-year extension option. The business has established itself as a leader in dispensing GLP-1 weight loss and diabetic medications, maintaining active insurance contracts while simultaneously serving a significant cash-based patient market.
The company's proprietary technology platform represents a significant competitive advantage, offering a fully integrated solution that provides a seamless experience for users, employees, and delivery drivers. This unique technological infrastructure opens potential white-label opportunities, positioning the business as an innovative frontrunner in the digital pharmacy ecosystem with minimal direct competition.
Due to seller confidentiality, detailed balance sheets, customer concentration, tax returns, and supplier agreements require executing our digital bilateral NDA.
Free for qualified buyers & acquisition searchers.
Calculate fair market enterprise value and compare EBITDA multiples against industry benchmarks.
Launch Valuation Calculator